These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1805495)
1. Mitogen induced proliferation and cytokine production by lymphocytes from leprosy patients. Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG Acta Leprol; 1991; 7(5):397-402. PubMed ID: 1805495 [TBL] [Abstract][Full Text] [Related]
2. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients. Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181 [TBL] [Abstract][Full Text] [Related]
3. Natural killer-cell-mediated and antibody-dependent cellular cytotoxicity in leprosy. Chiplunkar SV; Deshmukh MV; Samson PD; Butlin R; Bhatki WS; Chulawalla RG; Deo MG; Gangal SG Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):334-41. PubMed ID: 2376683 [TBL] [Abstract][Full Text] [Related]
4. Immunologic defects in leprosy patients. II. Interleukin 1, interleukin 2, and interferon production in leprosy patients. Makonkawkeyoon S; Kasinrerk W; Supajatura V; Hirunpetcharat C; Vithayasai V Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):311-8. PubMed ID: 1695911 [TBL] [Abstract][Full Text] [Related]
5. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [TBL] [Abstract][Full Text] [Related]
6. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy. Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756 [TBL] [Abstract][Full Text] [Related]
7. Production of host-protective (IFN-gamma), host-impairing (IL-10, IL-13) and inflammatory (TNF-alpha) cytokines by PBMC from leprosy patients stimulated with mycobacterial antigens. Machado P; Abrams J; Santos S; Brennan P; Barral A; Barral-Netto M Eur J Dermatol; 1998 Mar; 8(2):98-103. PubMed ID: 9649657 [TBL] [Abstract][Full Text] [Related]
8. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851 [TBL] [Abstract][Full Text] [Related]
9. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy. Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947 [TBL] [Abstract][Full Text] [Related]
10. Lepromatous and tuberculoid leprosy: clinical presentation and cytokine responses. Ochoa MT; Valderrama L; Ochoa A; Zea A; Escobar CE; Moreno LH; Falabella R Int J Dermatol; 1996 Nov; 35(11):786-90. PubMed ID: 8915730 [TBL] [Abstract][Full Text] [Related]
11. Serum IL-1ra is elevated in lepromatous leprosy patients. Fafutis-Morris M; Guillen-Vargas CM; Navarro-Fierro S; Morales-Ortiz R; Armendariz-Borunda J Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):287-91. PubMed ID: 10575408 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. Sieling PA; Abrams JS; Yamamura M; Salgame P; Bloom BR; Rea TH; Modlin RL J Immunol; 1993 Jun; 150(12):5501-10. PubMed ID: 8515073 [TBL] [Abstract][Full Text] [Related]
13. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy. Kumar A; Girdhar A; Girdhar BK Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703 [TBL] [Abstract][Full Text] [Related]
14. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy. Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736 [TBL] [Abstract][Full Text] [Related]
15. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy. Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953 [TBL] [Abstract][Full Text] [Related]
16. Silent iritis in treated bacillary negative leprosy. Thompson K; Job CK Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265 [TBL] [Abstract][Full Text] [Related]
17. Blastogenic response with autologous plasma and Mitsuda's reaction in leprosy patients and their unaffected sibs. Foss NT; Pagnano PM; Bechelli LM; Lima Filho EC Acta Leprol; 1991; 7(4):335-45. PubMed ID: 1950443 [TBL] [Abstract][Full Text] [Related]
18. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report. Kar BR; Job CK Lepr Rev; 2005 Sep; 76(3):258-62. PubMed ID: 16248213 [TBL] [Abstract][Full Text] [Related]
19. Adenosine deaminase activity in leprosy. Suri Babu SS; Kannan KB; Katoch VM; Bharadwaj VP Indian J Lepr; 1990; 62(4):473-7. PubMed ID: 2086683 [TBL] [Abstract][Full Text] [Related]
20. Accessory cell heterogeneity in lepromatous leprosy; dendritic cells and not monocytes support T cell responses. Mittal A; Mishra RS; Nath I Clin Exp Immunol; 1989 May; 76(2):233-9. PubMed ID: 2503276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]